CN Stock MarketDetailed Quotes

002693 Hainan Shuangcheng Pharmaceuticals

Watchlist
  • 4.40
  • -0.04-0.90%
Market Closed Jun 28 15:00 CST
1.83BMarket Cap-28571P/E (TTM)

Hainan Shuangcheng Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-47.52%42.76M
-14.13%235.93M
-7.89%182.25M
9.62%139.01M
11.27%81.49M
-14.22%274.75M
-21.11%197.86M
-26.98%126.81M
-12.57%73.23M
18.87%320.29M
Operating revenue
-47.52%42.76M
-14.13%235.93M
-7.89%182.25M
9.62%139.01M
11.27%81.49M
-14.22%274.75M
-21.11%197.86M
-26.98%126.81M
-12.57%73.23M
18.87%320.29M
Other operating revenue
----
-80.06%4.87M
----
-22.96%9.26M
----
45.95%24.42M
----
-10.11%12.01M
----
-6.83%16.74M
Total operating cost
-32.46%57.36M
-15.50%278.16M
-8.88%213.05M
-2.17%150.37M
2.62%84.92M
-12.68%329.19M
-18.39%233.83M
-20.13%153.7M
-12.76%82.75M
11.00%377M
Operating cost
-28.21%17.08M
-15.21%74.86M
-16.78%53.86M
-4.49%39.84M
-2.61%23.79M
8.48%88.29M
6.61%64.72M
2.62%41.71M
23.04%24.43M
35.24%81.39M
Operating tax surcharges
-20.05%1.5M
-13.81%6.65M
-6.66%5.1M
0.61%3.59M
8.20%1.88M
9.68%7.71M
7.92%5.46M
14.97%3.57M
-9.68%1.73M
-2.06%7.03M
Operating expense
-60.75%14.6M
-18.41%102.97M
-11.43%80.6M
3.23%61.02M
9.05%37.2M
-33.42%126.2M
-39.81%90.99M
-43.73%59.11M
-33.59%34.11M
13.18%189.54M
Administration expense
13.45%19.16M
-6.12%76.26M
3.80%60.29M
-5.48%36.58M
-6.85%16.89M
3.42%81.23M
4.55%58.08M
8.96%38.71M
11.63%18.13M
-4.22%78.54M
Financial expense
-23.38%1.97M
-15.18%9.47M
-11.24%7.24M
-10.74%4.87M
0.04%2.57M
12.98%11.17M
13.95%8.16M
19.18%5.46M
7.21%2.57M
-7.05%9.88M
-Interest expense (Financial expense)
-21.28%2M
-14.36%9.58M
-12.35%7.37M
-7.39%5.11M
-0.12%2.54M
23.87%11.19M
23.58%8.41M
20.21%5.51M
5.85%2.55M
-9.75%9.03M
-Interest Income (Financial expense)
25.00%-7.63K
44.07%-34.48K
55.52%-28.6K
53.63%-18.97K
68.32%-10.17K
-15.90%-61.66K
-19.60%-64.3K
-2.06%-40.9K
-2.43%-32.1K
40.44%-53.2K
Research and development
17.46%3.04M
-45.49%7.96M
-6.93%5.97M
-13.37%4.46M
46.39%2.59M
37.43%14.59M
-6.65%6.41M
44.96%5.15M
-42.33%1.77M
-12.79%10.62M
Credit Impairment Loss
-113.65%-20.03K
-1,330.99%-1.15M
6.62%172.6K
497.45%213.21K
248.19%146.72K
127.84%93.3K
528.54%161.88K
-44.65%-53.64K
53.10%-99.01K
100.90%40.95K
Asset Impairment Loss
----
-12.21%-3.55M
--24.04K
--346.31
----
-11.48%-3.17M
----
----
----
71.04%-2.84M
Other net revenue
-88.31%416.07K
-168.09%-30.93M
-41.00%12.99M
-49.43%10.14M
-49.38%3.56M
149.99%45.42M
18.52%22.02M
14.05%20.05M
139.28%7.03M
312.38%18.17M
Fair value change income
-103.88%-61.14K
-70,844.66%-39.85M
-90.95%141.51K
-42.18%1.1M
--1.58M
---56.18K
--1.56M
--1.9M
----
----
Invest income
4.14%183.11K
-41.29%2.75M
74.92%2.61M
478.14%1.44M
84.86%175.82K
13.92%4.69M
-38.59%1.49M
-88.00%248.77K
-95.39%95.11K
44.61%4.12M
Asset deal income
-101.03%-4.89K
-98.44%467.61K
-92.01%467.61K
-91.88%475.18K
--475.3K
116.86%29.91M
-57.42%5.86M
-57.44%5.86M
----
1,240.08%13.79M
Other revenue
-73.07%319.03K
-25.39%10.41M
-26.05%9.57M
-42.86%6.91M
-83.16%1.18M
356.15%13.95M
446.72%12.94M
579.26%12.1M
546.27%7.04M
-26.79%3.06M
Operating profit
-11,818.93%-14.18M
-711.78%-73.15M
-27.73%-17.81M
82.21%-1.22M
104.86%120.99K
76.62%-9.01M
18.58%-13.95M
-464.41%-6.84M
69.46%-2.49M
51.06%-38.54M
Add:Non operating Income
-99.73%1
141.21%564.66K
-35.02%444.64K
-34.20%444.25K
-69.73%373.29
83.14%234.1K
3,139.34%684.23K
3,149.01%675.16K
25.63%1.23K
-83.23%127.82K
Less:Non operating expense
-36.14%12.03K
265.65%378.65K
-57.90%40.61K
-47.09%37.01K
350.26%18.83K
-94.68%103.55K
-92.42%96.45K
-94.49%69.96K
-71.08%4.18K
147.25%1.95M
Total profit
-13,940.50%-14.19M
-721.62%-72.97M
-30.33%-17.41M
87.01%-810.02K
104.11%102.53K
77.99%-8.88M
27.32%-13.36M
-153.35%-6.24M
69.48%-2.49M
48.77%-40.36M
Less:Income tax cost
----
-157.58%-991.59K
-98.79%25.18K
-98.79%25.18K
---955.03
-185.56%-384.96K
--2.09M
--2.09M
----
-61.53%449.95K
Net profit
SL-14.19M
FPtoL-71.98M
FPtoL-17.44M
FPtoL-835.19K
FLtoP103.48K
FPtoL-8.5M
FPtoL-15.45M
FPtoL-8.32M
FPtoL-2.49M
FPtoL-40.81M
Net profit from continuing operation
-13,812.77%-14.19M
-747.18%-71.98M
-12.88%-17.44M
89.97%-835.19K
104.15%103.48K
79.18%-8.5M
15.97%-15.45M
-238.10%-8.32M
69.48%-2.49M
48.96%-40.81M
Less:Minority Profit
-23.76%-5.45M
-21.28%-21.23M
-33.74%-15.81M
-47.86%-9.63M
-36.60%-4.4M
14.52%-17.51M
17.58%-11.82M
23.04%-6.51M
32.71%-3.22M
23.05%-20.48M
Net profit of parent company owners
-294.04%-8.74M
-663.02%-50.74M
55.24%-1.62M
584.62%8.79M
517.11%4.51M
144.34%9.01M
10.25%-3.62M
-130.25%-1.81M
121.62%730.12K
61.89%-20.33M
Earning per share
Basic earning per share
-291.82%-0.0211
-700.00%-0.12
61.00%-0.0039
575.56%0.0214
511.11%0.011
140.00%0.02
0.00%-0.01
-145.00%-0.0045
118.00%0.0018
61.54%-0.05
Diluted earning per share
-291.82%-0.0211
-700.00%-0.12
61.00%-0.0039
575.56%0.0214
511.11%0.011
140.00%0.02
0.00%-0.01
-145.00%-0.0045
118.00%0.0018
61.54%-0.05
Other composite income
-290.61%-2.85K
123.75%6.38K
120.61%1.73K
241.16%10.16K
132.60%1.5K
-63.69%2.85K
-388.57%-8.38K
-570.55%-7.2K
-420.48%-4.59K
2,050.51%7.85K
Other composite income of parent company owners
-290.61%-2.85K
123.75%6.38K
120.61%1.73K
241.16%10.16K
132.60%1.5K
-63.69%2.85K
-388.57%-8.38K
-570.55%-7.2K
-420.48%-4.59K
2,050.51%7.85K
Total composite income
-13,619.93%-14.19M
-747.39%-71.97M
-12.81%-17.43M
90.10%-825.04K
104.20%104.98K
79.18%-8.49M
15.91%-15.45M
-238.60%-8.33M
69.42%-2.5M
48.97%-40.8M
Total composite income of parent company owners
-294.04%-8.75M
-662.77%-50.74M
55.39%-1.62M
583.27%8.8M
521.22%4.51M
144.37%9.02M
9.98%-3.63M
-130.36%-1.82M
121.49%725.53K
61.90%-20.32M
Total composite income of minority owners
-23.76%-5.45M
-21.28%-21.23M
-33.74%-15.81M
-47.86%-9.63M
-36.60%-4.4M
14.52%-17.51M
17.58%-11.82M
23.04%-6.51M
32.71%-3.22M
23.05%-20.48M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shanghui Certified Public Accountants (Special General Partnership)
--
--
--
Shanghui Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -47.52%42.76M-14.13%235.93M-7.89%182.25M9.62%139.01M11.27%81.49M-14.22%274.75M-21.11%197.86M-26.98%126.81M-12.57%73.23M18.87%320.29M
Operating revenue -47.52%42.76M-14.13%235.93M-7.89%182.25M9.62%139.01M11.27%81.49M-14.22%274.75M-21.11%197.86M-26.98%126.81M-12.57%73.23M18.87%320.29M
Other operating revenue -----80.06%4.87M-----22.96%9.26M----45.95%24.42M-----10.11%12.01M-----6.83%16.74M
Total operating cost -32.46%57.36M-15.50%278.16M-8.88%213.05M-2.17%150.37M2.62%84.92M-12.68%329.19M-18.39%233.83M-20.13%153.7M-12.76%82.75M11.00%377M
Operating cost -28.21%17.08M-15.21%74.86M-16.78%53.86M-4.49%39.84M-2.61%23.79M8.48%88.29M6.61%64.72M2.62%41.71M23.04%24.43M35.24%81.39M
Operating tax surcharges -20.05%1.5M-13.81%6.65M-6.66%5.1M0.61%3.59M8.20%1.88M9.68%7.71M7.92%5.46M14.97%3.57M-9.68%1.73M-2.06%7.03M
Operating expense -60.75%14.6M-18.41%102.97M-11.43%80.6M3.23%61.02M9.05%37.2M-33.42%126.2M-39.81%90.99M-43.73%59.11M-33.59%34.11M13.18%189.54M
Administration expense 13.45%19.16M-6.12%76.26M3.80%60.29M-5.48%36.58M-6.85%16.89M3.42%81.23M4.55%58.08M8.96%38.71M11.63%18.13M-4.22%78.54M
Financial expense -23.38%1.97M-15.18%9.47M-11.24%7.24M-10.74%4.87M0.04%2.57M12.98%11.17M13.95%8.16M19.18%5.46M7.21%2.57M-7.05%9.88M
-Interest expense (Financial expense) -21.28%2M-14.36%9.58M-12.35%7.37M-7.39%5.11M-0.12%2.54M23.87%11.19M23.58%8.41M20.21%5.51M5.85%2.55M-9.75%9.03M
-Interest Income (Financial expense) 25.00%-7.63K44.07%-34.48K55.52%-28.6K53.63%-18.97K68.32%-10.17K-15.90%-61.66K-19.60%-64.3K-2.06%-40.9K-2.43%-32.1K40.44%-53.2K
Research and development 17.46%3.04M-45.49%7.96M-6.93%5.97M-13.37%4.46M46.39%2.59M37.43%14.59M-6.65%6.41M44.96%5.15M-42.33%1.77M-12.79%10.62M
Credit Impairment Loss -113.65%-20.03K-1,330.99%-1.15M6.62%172.6K497.45%213.21K248.19%146.72K127.84%93.3K528.54%161.88K-44.65%-53.64K53.10%-99.01K100.90%40.95K
Asset Impairment Loss -----12.21%-3.55M--24.04K--346.31-----11.48%-3.17M------------71.04%-2.84M
Other net revenue -88.31%416.07K-168.09%-30.93M-41.00%12.99M-49.43%10.14M-49.38%3.56M149.99%45.42M18.52%22.02M14.05%20.05M139.28%7.03M312.38%18.17M
Fair value change income -103.88%-61.14K-70,844.66%-39.85M-90.95%141.51K-42.18%1.1M--1.58M---56.18K--1.56M--1.9M--------
Invest income 4.14%183.11K-41.29%2.75M74.92%2.61M478.14%1.44M84.86%175.82K13.92%4.69M-38.59%1.49M-88.00%248.77K-95.39%95.11K44.61%4.12M
Asset deal income -101.03%-4.89K-98.44%467.61K-92.01%467.61K-91.88%475.18K--475.3K116.86%29.91M-57.42%5.86M-57.44%5.86M----1,240.08%13.79M
Other revenue -73.07%319.03K-25.39%10.41M-26.05%9.57M-42.86%6.91M-83.16%1.18M356.15%13.95M446.72%12.94M579.26%12.1M546.27%7.04M-26.79%3.06M
Operating profit -11,818.93%-14.18M-711.78%-73.15M-27.73%-17.81M82.21%-1.22M104.86%120.99K76.62%-9.01M18.58%-13.95M-464.41%-6.84M69.46%-2.49M51.06%-38.54M
Add:Non operating Income -99.73%1141.21%564.66K-35.02%444.64K-34.20%444.25K-69.73%373.2983.14%234.1K3,139.34%684.23K3,149.01%675.16K25.63%1.23K-83.23%127.82K
Less:Non operating expense -36.14%12.03K265.65%378.65K-57.90%40.61K-47.09%37.01K350.26%18.83K-94.68%103.55K-92.42%96.45K-94.49%69.96K-71.08%4.18K147.25%1.95M
Total profit -13,940.50%-14.19M-721.62%-72.97M-30.33%-17.41M87.01%-810.02K104.11%102.53K77.99%-8.88M27.32%-13.36M-153.35%-6.24M69.48%-2.49M48.77%-40.36M
Less:Income tax cost -----157.58%-991.59K-98.79%25.18K-98.79%25.18K---955.03-185.56%-384.96K--2.09M--2.09M-----61.53%449.95K
Net profit SL-14.19MFPtoL-71.98MFPtoL-17.44MFPtoL-835.19KFLtoP103.48KFPtoL-8.5MFPtoL-15.45MFPtoL-8.32MFPtoL-2.49MFPtoL-40.81M
Net profit from continuing operation -13,812.77%-14.19M-747.18%-71.98M-12.88%-17.44M89.97%-835.19K104.15%103.48K79.18%-8.5M15.97%-15.45M-238.10%-8.32M69.48%-2.49M48.96%-40.81M
Less:Minority Profit -23.76%-5.45M-21.28%-21.23M-33.74%-15.81M-47.86%-9.63M-36.60%-4.4M14.52%-17.51M17.58%-11.82M23.04%-6.51M32.71%-3.22M23.05%-20.48M
Net profit of parent company owners -294.04%-8.74M-663.02%-50.74M55.24%-1.62M584.62%8.79M517.11%4.51M144.34%9.01M10.25%-3.62M-130.25%-1.81M121.62%730.12K61.89%-20.33M
Earning per share
Basic earning per share -291.82%-0.0211-700.00%-0.1261.00%-0.0039575.56%0.0214511.11%0.011140.00%0.020.00%-0.01-145.00%-0.0045118.00%0.001861.54%-0.05
Diluted earning per share -291.82%-0.0211-700.00%-0.1261.00%-0.0039575.56%0.0214511.11%0.011140.00%0.020.00%-0.01-145.00%-0.0045118.00%0.001861.54%-0.05
Other composite income -290.61%-2.85K123.75%6.38K120.61%1.73K241.16%10.16K132.60%1.5K-63.69%2.85K-388.57%-8.38K-570.55%-7.2K-420.48%-4.59K2,050.51%7.85K
Other composite income of parent company owners -290.61%-2.85K123.75%6.38K120.61%1.73K241.16%10.16K132.60%1.5K-63.69%2.85K-388.57%-8.38K-570.55%-7.2K-420.48%-4.59K2,050.51%7.85K
Total composite income -13,619.93%-14.19M-747.39%-71.97M-12.81%-17.43M90.10%-825.04K104.20%104.98K79.18%-8.49M15.91%-15.45M-238.60%-8.33M69.42%-2.5M48.97%-40.8M
Total composite income of parent company owners -294.04%-8.75M-662.77%-50.74M55.39%-1.62M583.27%8.8M521.22%4.51M144.37%9.02M9.98%-3.63M-130.36%-1.82M121.49%725.53K61.90%-20.32M
Total composite income of minority owners -23.76%-5.45M-21.28%-21.23M-33.74%-15.81M-47.86%-9.63M-36.60%-4.4M14.52%-17.51M17.58%-11.82M23.04%-6.51M32.71%-3.22M23.05%-20.48M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shanghui Certified Public Accountants (Special General Partnership)------Shanghui Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg